C4 Therapeutics, Inc.
Ticker: 1662579
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.64+8.0% | 6.15-45.2% | 11.23+73.8% | 6.46-10.8% | 7.24-52.9% | 15.36+27.9% | 12.01+295.1% | 3.04 |
| Total Income | 6.64+8.0% | 6.15-45.2% | 11.23+73.8% | 6.46-10.8% | 7.24-52.9% | 15.36+27.9% | 12.01+295.1% | 3.04 |
| EXPENSES | ||||||||
| Expenditure | 33.06-2.6% | 33.94-25.6% | 45.64+30.5% | 34.96-4.0% | 36.40-16.5% | 43.61+30.4% | 33.45-5.1% | 35.26 |
| Tax | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | — | — | -32.17-23.6% | -26.02+1.1% | -26.32-6.7% | -24.67-39.2% | -17.72+37.5% | -28.36 |
| Net Profit | -23.64+5.9% | -25.13+21.9% | -32.17-23.6% | -26.02+1.1% | -26.32-6.7% | -24.67-39.2% | -17.72+37.5% | -28.36 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.18+10.0% | -0.20+54.5% | -0.44-18.9% | -0.37+0.0% | -0.37-5.7% | -0.35-34.6% | -0.26+36.6% | -0.41 |
Corporate Events
Board MeetingCCCC
202624Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of Cl…
SEC Filing ↗ Board MeetingCCCC
202615May
Board Meeting
Chief Accounting Officer Transition — Mark Mossler departs, …
SEC Filing ↗